FDAnews Announces -- Drug Regulation in China: Updates, Key Issues and Common Challenges Webinar, Sept. 24, 2019

Tuesday, September 10, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Expert on drug regulation in China provides key updates.

FALLS CHURCH, Va., Sept. 10, 2019 /PRNewswire-PRWeb/ -- Drug Regulation in China Updates,

Key Issues and Common Challenges An FDAnews Webinar Tuesday, Sept. 24, 2019, 1:30-3:00 p.m. EDT https://www.fdanews.com/drugregchina

If business is currently being done in China or being considered in the China market, this is a must-attend webinar.

Recent reforms coupled with seemingly ever-changing drug regulations makes navigating the drug regulatory lifecycle in China quite the challenge. It significantly impacts pharmaceutical companies doing business there or looking to enter the China market.

John Balzano, Esq., a partner at Covington & Burling LLP with over a decade of experience in legal and regulatory issues related to healthcare products and services in China, will provide one with valuable insights on:

  • Important new regulatory reforms in China related to drug development, including 60-day notification of clinical trial applications, priority review and GCP enforcement
  • Revisions to Human Genetic Resource (HGR) regulations, such as the new notification system and the continued approval system for exploratory research
  • How to prepare for overseas inspections and compliance with emerging distribution and manufacturing rules
  • How to make sense of the recent guidance documents coming out of China including guidance on foreign data and new application modules

This is the opportunity to understand the recent developments in drug regulation in China — and make them work for the business.

Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details: Drug Regulation in China Updates, Key Issues and Common Challenges An FDAnews Webinar Tuesday, Sept. 24, 2019, 1:30-3:00 p.m. EDT https://www.fdanews.com/drugregchina

Tuition: $287 per site

Easy Ways to Register: Online: fdanews.com/drugregchina?hittrk=1991VOCUS https://www.fdanews.com/drugregchina By phone: 888-838-5578 or 703-538-7600

About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDAnews



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store